Cypress Capital Management »

SPDR S&P Biotech shares owned by Cypress Capital Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Cypress Capital Management from 13F filings

Historical chart of Cypress Capital Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Cypress Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Cypress Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.7k 47 121.94
2018-09-30 $198k 2.1k 95.88
2018-06-30 $197k 2.1k 95.40
2018-03-31 $119k 1.4k 87.50

More positions owned by Cypress Capital Management

Apple (AAPL)
Nuveen Nasdaq 100 Dynamic Ov Com Shs (QQQX)
Eaton Vance Tax Managed Diversified Eq. (ETY)
Yd Bio *w Exp 08/28/203 (YDESW)
BlackRock Global Energy & Resources Trus (BGR)
Costco Wholesale Corporation (COST)
Royce Value Trust (RVT)
Sprott Etf Trust Jr Gold Miners E (PHYS)
Ishares Tr S&P SML 600GWT (IJT)
JPMorgan Chase & Co. (JPM)
Alamos Gold Com Cl A (AGI)
Alps Etf Tr Alerian Mlp (AMLP)
Cameco Corporation (CCJ)
Philip Morris International (PM)
Celestica (CLS)

View all positions for Cypress Capital Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Susquehanna International
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Deep Track Capital
Jane Street
Citadel Advisors
UBS Group
Millennium Management
Point72 Asset Management
Peak6
Wells Fargo & Company
Soleus Capital Management
Barclays

View all funds holding SPDR S&P Biotech